☆ 4.7 Article

Long-term evolution in liver disease markers and immune and lipid profiles in vertically HIV/HCV-coinfected youths with sustained viral response after direct-acting antivirals therapy

BIOMEDICINE & PHARMACOTHERAPY (2023)

Related references

Note: Only part of the references are listed.

Article Infectious Diseases

Transient Viral Rebound in Children with Perinatally Acquired HIV-1 Induces a Unique Soluble Immunometabolic Signature Associated with Decreased CD4/CD8 Ratio

Laura Tarancon-Diez et al.

Summary: The study examined the changes in metabolites, lipids, and proteins in children with perinatally acquired HIV-1 (PHIV) following transient viral rebound (tVR). The results showed a decrease in the CD4/CD8 ratio in children with tVR. Significant differences were observed in certain soluble proteins, lipids, and metabolites after tVR, which correlated with immunological parameters, specifically the CD4/CD8 ratio.

JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2023)

Add to Collection

Article Immunology

Hepatitis C Virus Treatment Response to Direct-acting Antivirals Among Adolescents With HIV/HCV Coinfection: Real-world Data From Ukraine

Farihah Malik et al.

Summary: This study evaluated the real-world safety and effectiveness of direct-acting antivirals (DAAs) in HIV/HCV coinfected adolescents from the Ukraine Paediatric HIV Cohort Study. The results showed that DAA treatment was well tolerated and effective in these patients.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2022)

Add to Collection

Article Infectious Diseases

Long-term evolution in liver fibrosis and immune profile after direct-acting antivirals therapy in hepatitis C virus-human immunodeficiency virus co-infected patients

Montserrat Laguno et al.

Summary: HCV therapy with DAA in PLWH leads to significant improvement in liver fibrosis and recovery of the immune system, as indicated by an increase in the CD4/CD8 ratio, in long-term follow-up.

CLINICAL MICROBIOLOGY AND INFECTION (2022)

Add to Collection

Article Medicine, Research & Experimental

Metabolomic changes after DAAs therapy are related to the improvement of cirrhosis and inflammation in HIV/HCV-coinfected patients

Ana Virseda-Berdices et al.

Summary: The plasma metabolomic profile of HIV/HCV-coinfected patients with advanced HCV-related cirrhosis changed after HCV clearance with direct-acting antivirals (DAAs). The changes in plasma levels of LPC(20:4), 2-keto-n-caproic acid/2-keto-isocaproic acid, and taurocholic acid were associated with improvements in cirrhosis scores and inflammatory status of patients.

BIOMEDICINE & PHARMACOTHERAPY (2022)

Add to Collection

Article Medicine, General & Internal

Real-Life Early Anthropometric, Lipid and Liver Changes after Direct-Acting Antiviral Therapy in PLWHIV with HCV Co-Infection

Sergio Ferra-Murcia et al.

Summary: DAAs treatment has early negative impact on lipid metabolism, while achieving SVR12 against HCV leads to early improvement in liver function and LS in HCV/HIV co-infected patients without interference with ART and DAAs.

JOURNAL OF CLINICAL MEDICINE (2022)

Add to Collection

Article Medicine, General & Internal

Evaluation of Cardiovascular Risk Factors after Hepatitis C Virus Eradication with Direct-Acting Antivirals in a Cohort of Treatment-Naive Patients without History of Cardiovascular Disease

Diego Casas-Deza et al.

Summary: DAA treatment improves plasma lipid levels and glycemic control in patients with HCV. Additionally, iron metabolism and coagulation function also improved. While two cardiovascular events were observed, overall DAA treatment did not increase the risk of cardiovascular events.

JOURNAL OF CLINICAL MEDICINE (2022)

Add to Collection

Article Immunology

Clinical, Immunological, and Virological Outcomes Among Youths With Perinatal HIV After Transition to Adult Units in Spain From 1997 to 2016

David Aguilera-Alonso et al.

Summary: This study aimed to describe the clinical and immunovirological status of patients with perinatal HIV after transitioning to adult care. The findings show that virological suppression improved in the early transition periods, but some patients had a higher risk of worse outcomes. Identifying these high-risk patients may help improve their transition process.

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2021)

Add to Collection

Article Oncology

Anthropometric parameters and liver histology influence lipid metabolic changes in HCV chronic hepatitis on direct-acting antiviral treatment

Domenico Iossa et al.

Summary: In patients with chronic hepatitis C (CHC) treated with direct-acting antivirals (DAAs), eradication of HCV leads to a pro-atherogenic lipid pattern. Changes in lipid metabolism depend on anthropometric parameters and liver histology. However, there is no significant increase in cardiovascular risk indexes in the short-term.

ANNALS OF TRANSLATIONAL MEDICINE (2021)

Add to Collection

Article Immunology

Innate and adaptive abnormalities in youth with vertically acquired HIV through a multicentre cohort in Spain

Itziar Carrasco et al.

Summary: Immune abnormalities were observed among youth with vertically acquired HIV despite ART, with high levels of activation and exhaustion in both T and NK cells. The CD4/CD8 ratio and age at ART initiation were associated with immune activation and exhaustion levels, indicating potential markers of disease progression.

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2021)

Add to Collection

Article Infectious Diseases

Modifications of CD4 T cells, CD4/CD8 ratio and serum levels of soluble CD14 in HIV-HCV-coinfected patients after sustained HCV response induced by direct-acting antiviral agents: influence of liver cirrhosis

Jose-Antonio Giron-Ortega et al.

Summary: The study analyzed the changes in CD4 T cell modifications, CD4/CD8 ratio, and serum levels of sCD14 in HIV/HCV-coinfected patients after treatment with direct anti-HCV antiviral agents. Results showed significant increases in CD4 T cell count and percentage only in individuals without liver cirrhosis, supporting the idea that treatment against HCV in HIV/HCV-coinfected patients is needed in the early phases of liver disease.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2021)

Add to Collection

Article Microbiology

Short- and Long-Term Immunological Responses in Chronic HCV/HIV Co-Infected Compared to HCV Mono-Infected Patients after DAA Therapy

Stefania Farcomeni et al.

Summary: The study evaluated the impact of HCV eradication following DAA therapy on the immune system and liver disease improvement among HCV mono-infected and HCV/HIV co-infected patients. Although patients achieved SVR 12, immune activation state remained elevated for a long time after DAA therapy, while liver-specific outcomes improved, highlighting distinct immunophenotypic and inflammatory biomarker profiles between the patient groups.

PATHOGENS (2021)

Add to Collection

Article Infectious Diseases

Early antiretroviral therapy initiation effect on metabolic profile in vertically HIV-1-infected children

Laura Tarancon-Diez et al.

Summary: This study characterized the proteomic, lipidomic, and metabolomic profiles of HIV-1-infected children based on the age at which they initiated cART. Differences in protein signatures were observed between early and late cART initiators, suggesting potential implications for metabolic disorders and non-AIDS conditions in this population. The findings underscore the importance of early antiretroviral treatment initiation in preventing long-term complications in perinatally acquired HIV-1-infected children.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)

Add to Collection

Article Immunology

HCV Cure With Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV/HCV-Coinfected Patients

Oscar Brochado-Kith et al.

Summary: In HIV/HCV coinfected patients with advanced HCV-related cirrhosis, eradication of HCV following DAA therapy resulted in improved liver disease markers, decreased plasma biomarkers, and reduced gene expression related to antiviral/inflammatory responses, particularly in levels of chemokines and ISGs.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Sustained virological response after treatment with direct-acting antivirals can help immune reconstitution in HIV-HCV coinfected patients even in case of persistent HIV low-level viremia

Monica Basso et al.

HEALTH SCIENCE REPORTS (2021)

Add to Collection

Article Gastroenterology & Hepatology

Longitudinal evolution of vertically HIV/HCV-co-infected vs HCV-mono-infected children

Talia Sainz et al.

JOURNAL OF VIRAL HEPATITIS (2020)

Add to Collection

Article Gastroenterology & Hepatology

Response to direct-acting antivirals for hepatitis C treatment in vertically HIV/HCV co-infected patients

Itziar Carrasco et al.

JOURNAL OF VIRAL HEPATITIS (2020)

Add to Collection

Article Microbiology

Modulation of Monocyte Activation and Function during Direct Antiviral Agent Treatment in Patients Coinfected with HIV and Hepatitis C Virus

Rebeca S. De Pablo-Bernal et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)

Add to Collection

Article Medicine, General & Internal

Carotid Intima-media Thickness and Small Dense Low-density Lipoprotein Cholesterol Increase after One Year of Treatment with Direct-acting Antivirals in Patients with Hepatitis C Virus Infection

Tatsuki Ichikawa et al.

INTERNAL MEDICINE (2019)

Add to Collection

Article Pharmacology & Pharmacy

Hepatitis C virus and cumulative infections are associated with atherogenic cardiovascular events in HIV-infected subjects

Miguel Genebat et al.

ANTIVIRAL RESEARCH (2019)

Add to Collection

Article Gastroenterology & Hepatology

Direct-acting antiviral therapy enhances total CD4+and CD8+T-cells responses, but does not alter T-cells activation among HCV mono-infected, and HCV/HIV-1 co-infected patients

Saeid Najafi Fard et al.

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2018)

Add to Collection

Article Medical Laboratory Technology

Exploring lipid and apolipoprotein levels in chronic hepatitis C patients according to their response to antiviral treatment

Gilmar de Souza Lacerda et al.

CLINICAL BIOCHEMISTRY (2018)

Add to Collection

Article Psychology, Developmental

Incidence of Postsuppression Virologic Rebound in Perinatally HIV-Infected Asian Adolescents on Stable Combination Antiretroviral Therapy

Tavitiya Sudjaritruk et al.

JOURNAL OF ADOLESCENT HEALTH (2017)

Add to Collection

Article Infectious Diseases

Systemic inflammation-based scores and mortality for all causes in HIV-infected patients: a MASTER cohort study

Elena Raffetti et al.

BMC INFECTIOUS DISEASES (2017)

Add to Collection

Article Immunology

Coinfection with HIV and hepatitis C virus in 229 children and young adults living in Europe

Claire Thorne et al.

AIDS (2017)

Add to Collection

Review Infectious Diseases

Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis

Lucy Platt et al.

LANCET INFECTIOUS DISEASES (2016)

Add to Collection

Article Immunology

CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study

Cristina Mussini et al.

LANCET HIV (2015)

Add to Collection

Article Infectious Diseases

A new tool for the paediatric HIV research: general data from the Cohort of the Spanish Paediatric HIV Network (CoRISpe)

Ma Isabel de Jose et al.

BMC INFECTIOUS DISEASES (2013)

Add to Collection

Article Infectious Diseases

Plasma metabolomics identifies lipid abnormalities linked to markers of inflammation, microbial translocation, and hepatic function in HIV patients receiving protease inhibitors

Edana Cassol et al.

BMC INFECTIOUS DISEASES (2013)

Add to Collection

Article Microbiology

Temporal Proteome and Lipidome Profiles Reveal Hepatitis C Virus-Associated Reprogramming of Hepatocellular Metabolism and Bioenergetics

Deborah L. Diamond et al.

PLOS PATHOGENS (2010)

Add to Collection

Article Gastroenterology & Hepatology

Hepatitis C Virus Infection and Its Clearance Alter Circulating Lipids: Implications for Long-Term Follow-Up

Kathleen E. Corey et al.

HEPATOLOGY (2009)

Add to Collection

Article Gastroenterology & Hepatology

Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection

A Vallet-Pichard et al.

JOURNAL OF HEPATOLOGY (2006)

Add to Collection

Article Immunology

Hepatitis C virus coinfection increases mortality in HIV-infected patients in the highly active antiretroviral therapy era: Data from the HIV Atlanta VA Cohort Study

KB Anderson et al.

CLINICAL INFECTIOUS DISEASES (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.